Ontology highlight
ABSTRACT:
SUBMITTER: Kim JH
PROVIDER: S-EPMC8189096 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
Kim Joon Hyung JH Diaz-Decaro John J Jiang Ning N Hwang Shinn-Jang SJ Choo Eun Ju EJ Co Maribel M Hastie Andrew A Hui David Shu Cheong DSC Irimajiri Junya J Lee Jacob J Leung Edward Man-Fuk EM Tang Haiwen H Tsuru Tomomi T Watson Philip P Wu Zhenhua Z Yu Chong-Jen CJ Yuan Yanfei Y Zahaf Toufik T Cunningham Anthony L AL Schuind Anne A
Human vaccines & immunotherapeutics 20210219 7
In two large clinical trials (ZOE-50 [NCT01165177] and ZOE-70 [NCT01165229]), two doses of the adjuvanted recombinant zoster vaccine (RZV) demonstrated >90% efficacy (VE) against herpes zoster (HZ) in adults ≥50 years of age (YOA). This post-hoc analysis assessed the VE against HZ and postherpetic neuralgia (PHN), in participants from Asian study sites enrolled in ZOE-50/70. Reactogenicity and safety were also assessed. Participants ≥50 YOA were randomized 1:1 to receive 2 doses of either RZV or ...[more]